Leszek Szczepanski
Overview
Explore the profile of Leszek Szczepanski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
1241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greenwald M, Szczepanski L, Kennedy A, Veenhuizen M, Komocsar W, Polasek E, et al.
Arthritis Res Ther
. 2014 Aug;
16(4):415.
PMID: 25168268
Introduction: The objective of this study was to evaluate the long-term safety and efficacy of tabalumab, a monoclonal antibody that neutralizes membrane-bound and soluble B-cell-activating factor, in rheumatoid arthritis (RA)...
2.
Richarz U, Waechter S, Sabatowski R, Szczepanski L, Binsfeld H
Pain Pract
. 2012 Apr;
13(1):30-40.
PMID: 22510252
Once-daily hydromorphone extended-release (OROS(®) hydromorphone ER) and oxycodone controlled-release (CR) are semisynthetic, ER opioid analgesics with established efficacy. An open-label, randomized, 24-week, parallel group, flexible-dose study demonstrated noninferiority of OROS...
3.
Binsfeld H, Szczepanski L, Waechter S, Richarz U, Sabatowski R
Pain Pract
. 2010 Apr;
10(5):404-15.
PMID: 20384968
This was a randomized, open-label, comparative, parallel group study designed to demonstrate the noninferiority of once-daily OROS(®) hydromorphone compared with twice-daily sustained-release (SR) oxycodone in subjects with chronic noncancer pain...
4.
van Vollenhoven R, Houbiers J, Buttgereit F, In t Hout J, Boers M, Leij S, et al.
Arthritis Rheum
. 2010 Jan;
62(2):351-8.
PMID: 20112368
Objective: Multiple lines of evidence suggest that sex hormones may play a role in the pathogenesis or clinical expression of rheumatoid arthritis (RA). Studies on the effects of exogenous estrogens...
5.
Szczepanski L
Pol Arch Med Wewn
. 2009 Jul;
118 Suppl:54-8.
PMID: 19562972
Disorders of soft, peri-articular tissues are a common cause of musculoskeletal pain in elderly patients. Nevertheless, most physicians underestimate the role of soft tissue rheumatism in the pathomechanism of the...
6.
Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, et al.
Arthritis Rheum
. 2006 May;
54(5):1390-400.
PMID: 16649186
Objective: To examine the efficacy and safety of different rituximab doses plus methotrexate (MTX), with or without glucocorticoids, in patients with active rheumatoid arthritis (RA) resistant to disease-modifying antirheumatic drugs...
7.
Scheiman J, Yeomans N, Talley N, Vakil N, Chan F, Tulassay Z, et al.
Am J Gastroenterol
. 2006 Feb;
101(4):701-10.
PMID: 16494585
Objectives: Proton pump inhibitors reduce ulcer recurrence in non-steroidal anti-inflammatory drug (NSAID) users, but their impact in at-risk ulcer-free patients using the current spectrum of prescribed agents has not been...
8.
Edwards J, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close D, et al.
N Engl J Med
. 2004 Jun;
350(25):2572-81.
PMID: 15201414
Background: An open-label study indicated that selective depletion of B cells with the use of rituximab led to sustained clinical improvements for patients with rheumatoid arthritis. To confirm these observations,...